Related Experiment Video
Updated: May 8, 2026

Studying Chronic Exposure of Mice to Ultraviolet B Radiation
Published on: August 19, 2025
BB-UVA vs. NB-UVB in the treatment of vitiligo: a randomized controlled clinical study (single blinded)
Medhat El-Mofty1, Wedad Mostafa, Randa Youssef
1Phototherapy Unit Kasr El-Aini, Faculty of Medicine, Cairo University, Cairo, Egypt.
Background:
Vitiligo is an acquired pigmentary disorder that affects between 1% and 2% of the general population. Phototherapy remains the cornerstone of treatment, with NB-UVB being the most frequently used. BB-UVA can be a plausible alternative for darker population; skin photo type III and IV.
Patients And Methods:
The study was a prospective, randomized, controlled, and single-blinded clinical trial, conducted on 40 patients with bilateral symmetrical vitiligo. The patients were randomly divided into two equal groups; group (A) received a fixed dose of 15 J/cm(2) BB-UVA, while group (B) received NB-UVB. The study was conducted for a period of 16 weeks (48 sessions).
Results:
The final percentage of clinical improvement was significantly higher (P = 0.047) within the BB-UVA group (63.82% ± 27.42), than within the NB-UVB group (44.32% ± 29.78).
Conclusion:
BB-UVA can be considered as an alternative treatment line for vitiligo.
Related Concept Videos
Blinding
Blind Procedures
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
